about
Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase IIHypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family EnterobacteriaceaeTopoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacinEfficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureusEvaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteriaMechanisms responsible for cross-resistance and dichotomous resistance among the quinolones.Mechanism of action of and resistance to quinolones.Integrating fluoroquinolones into the hospital formulary.Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infectionRegistration of disinfectants based on relative microbicidal activity.Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected].Control of fluoroquinolone resistance through successful regulation, AustraliaGlobal fluoroquinolone resistance epidemiology and implictions for clinical use.Mutant selection window hypothesis updated.Bacterial resistance to ciprofloxacin in Greece: results from the National Electronic Surveillance System. Greek Network for the Surveillance of Antimicrobial Resistance.The use of platensimycin and platencin to fight antibiotic resistance.Risks Involved in the Use of Enrofloxacin for Salmonella Enteritidis or Salmonella Heidelberg in Commercial Poultry.Quinolones: action and resistance updated.Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals.Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposureTopoisomerase mutations in trovafloxacin-resistant Staphylococcus aureusActivities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria.Comparison of the selection of antimicrobial resistance in fecal Escherichia coli during enrofloxacin administration with a local drug delivery system or with intramuscular injections in a swine model.Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus.Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus.Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV.Ciprofloxacin release using natural rubber latex membranes as carrier.Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant.A survey of fluoroquinolone resistance in Escherichia coli and thermophilic Campylobacter spp. on poultry and pig farms in Great Britain.Ciprofloxacin-resistant Escherichia coli in hospital wastewater of Bangladesh and prediction of its mechanism of resistance.Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.Editorial: Alternatives to Antimicrobial Growth Promoters and Their Impact in Gut Microbiota, Health and Disease.
P2860
Q28265803-B843263E-5531-42B3-B212-2D4ECF672FE7Q30448695-27E5AB38-ACF8-4F8F-883E-131F7D1D04CBQ33770211-D8D400B9-267E-496D-9301-E39EE9B57630Q33959148-DC9C369B-127C-4491-B35F-5E33C0688424Q33977109-F79C6CFC-6C19-4B52-A573-E188DDE1C237Q33978084-BAB6C9B3-1197-49C3-BFA5-78BBADEE9209Q33981224-1DC527C4-7838-4399-9EFA-679CA87181B6Q34010692-E63BEE5D-C0AA-4CDB-AE12-AD991910A04BQ34183514-E3B2ECEE-1A10-4DB3-AB19-DD253EF106F3Q34408434-4D7A4528-FA92-4934-AD1A-3F166E7EBE88Q34408454-C683F070-B34E-4959-BAF7-B53A58001D63Q34560162-FB3C1476-CE1A-4489-A459-EBCD2BC8E5FEQ35005092-DEE8DED5-536C-4C9A-9BC1-D95D2F1F2614Q35598552-C1395142-53C8-472C-8CFB-84E94B429C9DQ35755953-B1226BED-FB47-48A6-B477-9BAAF320A0A7Q36173899-1C57C3F3-BA12-46D9-9393-24F9BF7ACC76Q36221182-B2430438-981D-4E9B-BE9E-B3CB8FDDA11EQ36337074-F9404538-FE3A-4F09-BC52-B8A5E52DDCC3Q36728061-D2D873DB-7D33-4E4F-8ED0-DD12A73AF1F2Q37093631-3D82019A-8DB5-49A2-84A4-1AEF16DC43C4Q37203095-6B24CC9F-A20D-4718-9CD0-194D282C8BC9Q37218171-30258C1F-7271-42F5-866B-AE71102060AAQ37595559-6AFF71C4-C261-446D-B4C0-8FC9DA5AC6C9Q38963042-5CCC4A41-E598-44EC-A1C7-304005FF6942Q39445995-6A6312DD-F6A9-457A-ACD6-B76352F337FAQ39471750-774F89F1-ADAD-417E-B7D2-F815EEC33565Q39559020-D3AC8AED-E9CD-44D8-8939-938698268382Q39559460-3FDBB36B-2D45-4E28-A3C7-9292BC531961Q39571968-7266C79C-6D95-41C2-863D-EE3B7E9F7B2DQ39656622-14D5C89C-5C38-438B-8DFF-08A841FCD72EQ39731893-C5BA753D-36EB-445B-B053-18A12E7B382DQ39789567-F2BC9B91-073D-4B3C-A31B-12166D0954B4Q40733777-D960CF65-CDDF-4062-B69D-34A80AD5DE5BQ41545884-F6A91C79-0812-4073-B4D9-D22421F35A48Q42027647-BEBAFFC5-1F81-419E-8D3C-1ED428C70E22Q43025314-7E3854D4-A0F6-4BE0-96E9-265E6397247EQ43481957-09810710-2C61-495E-A4DC-9B0E56C51CCBQ44840003-4CB14F85-239E-4950-9B7D-D47F53AC6A9EQ45170005-C8A3C06A-9AB1-46D4-97DB-CA0FC4076D5CQ45849813-1A37DEE3-23D2-43B6-965B-163547A1CEEE
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Trends in bacterial resistance to fluoroquinolones.
@en
type
label
Trends in bacterial resistance to fluoroquinolones.
@en
prefLabel
Trends in bacterial resistance to fluoroquinolones.
@en
P1476
Trends in bacterial resistance to fluoroquinolones.
@en
P2093
P304
P356
10.1093/CLINIDS/24.SUPPLEMENT_1.S67
P407
P478
24 Suppl 1
P577
1997-01-01T00:00:00Z